Professor | Yaping Li | Asia Growth Partners

Name	Yaping Li
Contact Information	ypli@simm.ac.cn
Language ability	Chinese, German, English
Province	Shanghai

Name

Yaping Li

Contact Information

ypli@simm.ac.cn

Language ability

Chinese, German, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2001-09--2002-12 Postdoctoral: Drug Research Center, University of Munich 1998-09--2001-06 PhD: Fudan University 1993-09--1996-06 Master's Degree: Shenyang Pharmaceutical University
Work Experience	2001-09--2002-12 - University of Munich - Postdoctoral 1998-09--2001-06 - Fudan University - PhD 1996-07--Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher/Associate Researcher/Researcher/Group Leader/Director 1993-09--1996-06 - Shenyang Pharmaceutical University - Master's Degree 1987-01--1993-08 - Hubei Anlu Pharmaceutical Factory - Technician/Assistant Engineer/Director/Section Chief
Awards	Shanghai Science and Technology Elite (2022): Provincial Level Wu Jieping Medical Innovation Award (2022): Ministerial Level First Prize for Key Technologies and Applications of Formulations to Improve the In Vivo Delivery Efficiency of Poorly Soluble Drugs (2022): Provincial Level Second Prize for Basic Research on the Application of New Nano Drug Delivery Systems to Overcome Tumor Chemotherapy Resistance (2020): National Level First Prize for Research on Drug Delivery Systems to Improve the Efficacy and Drugability of Poorly Soluble Drugs (2020): Other Wu Jieping-Paul Janssen Medical and Pharmaceutical Award (2018): Other China Pharmaceutical Association-Yiling Biomedical Innovation Award (2018): Other National Ten Thousand Talents Program for Leading Scientific and Technological Innovation (2017): Ministerial Level First Prize of the China Pharmaceutical Association Science and Technology Award (2015): Ministerial Level National Outstanding Young and Middle-aged Expert with Outstanding Contributions (2015): Ministerial Level National Hundred, Thousand, and Ten Thousand Talent Project (2015): Ministerial Level Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2014): Institutional Level First Prize of Shanghai Pharmaceutical Science and Technology Award (2013): Provincial Level WuXi AppTec Life Chemistry Scholar Award (2013): Other Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2012): Institutional Level Shanghai Outstanding Academic Leader (2011): Provincial Level Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2011): Institutional Level Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2010): Institutional Level Shanghai Leading Talent (2010): Provincial Level Zhu Li Yuehua Excellent Teacher Award of the Chinese Academy of Sciences (2010): Institutional Level First Prize of Shanghai Pharmaceutical Science and Technology Award (2009): Provincial Level Third Prize of the China Pharmaceutical Science and Technology Award (2008): Ministerial Level

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2001-09--2002-12 Postdoctoral: Drug Research Center, University of Munich
1998-09--2001-06 PhD: Fudan University
1993-09--1996-06 Master's Degree: Shenyang Pharmaceutical University

Work Experience

2001-09--2002-12 - University of Munich - Postdoctoral
1998-09--2001-06 - Fudan University - PhD
1996-07--Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher/Associate Researcher/Researcher/Group Leader/Director
1993-09--1996-06 - Shenyang Pharmaceutical University - Master's Degree
1987-01--1993-08 - Hubei Anlu Pharmaceutical Factory - Technician/Assistant Engineer/Director/Section Chief

Awards

Shanghai Science and Technology Elite (2022): Provincial Level
Wu Jieping Medical Innovation Award (2022): Ministerial Level
First Prize for Key Technologies and Applications of Formulations to Improve the In Vivo Delivery Efficiency of Poorly Soluble Drugs (2022): Provincial Level
Second Prize for Basic Research on the Application of New Nano Drug Delivery Systems to Overcome Tumor Chemotherapy Resistance (2020): National Level
First Prize for Research on Drug Delivery Systems to Improve the Efficacy and Drugability of Poorly Soluble Drugs (2020): Other
Wu Jieping-Paul Janssen Medical and Pharmaceutical Award (2018): Other
China Pharmaceutical Association-Yiling Biomedical Innovation Award (2018): Other
National Ten Thousand Talents Program for Leading Scientific and Technological Innovation (2017): Ministerial Level
First Prize of the China Pharmaceutical Association Science and Technology Award (2015): Ministerial Level
National Outstanding Young and Middle-aged Expert with Outstanding Contributions (2015): Ministerial Level
National Hundred, Thousand, and Ten Thousand Talent Project (2015): Ministerial Level
Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2014): Institutional Level
First Prize of Shanghai Pharmaceutical Science and Technology Award (2013): Provincial Level
WuXi AppTec Life Chemistry Scholar Award (2013): Other
Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2012): Institutional Level
Shanghai Outstanding Academic Leader (2011): Provincial Level
Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2011): Institutional Level
Outstanding Graduate Supervisor of the Chinese Academy of Sciences (2010): Institutional Level
Shanghai Leading Talent (2010): Provincial Level
Zhu Li Yuehua Excellent Teacher Award of the Chinese Academy of Sciences (2010): Institutional Level
First Prize of Shanghai Pharmaceutical Science and Technology Award (2009): Provincial Level
Third Prize of the China Pharmaceutical Science and Technology Award (2008): Ministerial Level

Areas of Focus	Nanomedicine and Targeted Drug Delivery
Publications	Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer, Yaping Li, 2024 Extracellular matrix-trapped bioinspired lipoprotein prolongs tumor retention to potentiate antitumor immunity, Yaping Li, 2024 STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy, Yaping Li, 2023 Enhancing the oral bioavailability of poorly water-soluble amisupiride with solid nanodispersion, Yaping Li, 2023 Breaking tumor immunosuppressive network by regulating multiple nodes with triadic drug delivery nanoparticles, Yaping Li, 2023 Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy, Yaping Li, 2023 Versatile biomimetic nanomedicine for treating cancer and inflammation disease, Yaping Li, 2023 Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells, Yaping Li, 2023 Gemcitabine-loaded synthetic high-density lipoprotein preferentially eradicates hepatic monocyte-derived macrophages in mouse liver with colorectal cancer metastases, Yaping Li, 2023 Macrophage membrane-coated nano-gemcitabine promotes lymphocyte infiltration and synergizes antiPD-L1 to restore the tumoricidal function., Yaping Li, 2023 Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy, Yaping Li, 2023 Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer, Yaping Li, 2023 Promote intratumoral drug release and penetration to counteract docetaxel-induced metastasis by photosensitizer-modified red blood cell membranes-coated nanoparticle., Yaping Li, 2023 Inhibiting endothelial cell-mediated T lymphocyte apoptosis with integrin-targeting peptide-drug conjugate filaments for chemoimmunotherapy of triple-negative breast cancer, Yaping Li, 2023 Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer, Yaping Li, 2023 Smart drug delivery systems to overcome drug resistance in cancer immunotherapy, Yaping Li, 2023 Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles, Yaping Li, 2023 Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy, Yaping Li, 2022 Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry, Yaping Li, 2022 Poly(maleic anhydride-alt-1-octadecene)-based bioadhesive nanovehicles improve oral bioavailability of poor water-soluble gefitinib, Yaping Li, 2022 Anti-hypoxia nanosized drug delivery systems improving cancer therapy, Yaping Li, 2022 Blocking Cholesterol Metabolism with Tumor-Penetrable Nanovesicles to Improve Photodynamic Cancer Immunotherapy, Yaping Li, 2022 Lenvatinib-and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer, Yaping Li, 2022 Current approaches of nanomedicines in the market and various stage of clinical translation, Yaping Li, 2022 Strategies of engineering nanomedicines for tumor retention, Yaping Li, 2022 Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast

Areas of Focus

Nanomedicine and Targeted Drug Delivery

Publications

Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer, Yaping Li, 2024
Extracellular matrix-trapped bioinspired lipoprotein prolongs tumor retention to potentiate antitumor immunity, Yaping Li, 2024
STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy, Yaping Li, 2023
Enhancing the oral bioavailability of poorly water-soluble amisupiride with solid nanodispersion, Yaping Li, 2023
Breaking tumor immunosuppressive network by regulating multiple nodes with triadic drug delivery nanoparticles, Yaping Li, 2023
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy, Yaping Li, 2023
Versatile biomimetic nanomedicine for treating cancer and inflammation disease, Yaping Li, 2023
Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells, Yaping Li, 2023
Gemcitabine-loaded synthetic high-density lipoprotein preferentially eradicates hepatic monocyte-derived macrophages in mouse liver with colorectal cancer metastases, Yaping Li, 2023
Macrophage membrane-coated nano-gemcitabine promotes lymphocyte infiltration and synergizes antiPD-L1 to restore the tumoricidal function., Yaping Li, 2023
Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy, Yaping Li, 2023
Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer, Yaping Li, 2023
Promote intratumoral drug release and penetration to counteract docetaxel-induced metastasis by photosensitizer-modified red blood cell membranes-coated nanoparticle., Yaping Li, 2023
Inhibiting endothelial cell-mediated T lymphocyte apoptosis with integrin-targeting peptide-drug conjugate filaments for chemoimmunotherapy of triple-negative breast cancer, Yaping Li, 2023
Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer, Yaping Li, 2023
Smart drug delivery systems to overcome drug resistance in cancer immunotherapy, Yaping Li, 2023
Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles, Yaping Li, 2023
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy, Yaping Li, 2022
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry, Yaping Li, 2022
Poly(maleic anhydride-alt-1-octadecene)-based bioadhesive nanovehicles improve oral bioavailability of poor water-soluble gefitinib, Yaping Li, 2022
Anti-hypoxia nanosized drug delivery systems improving cancer therapy, Yaping Li, 2022
Blocking Cholesterol Metabolism with Tumor-Penetrable Nanovesicles to Improve Photodynamic Cancer Immunotherapy, Yaping Li, 2022
Lenvatinib-and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer, Yaping Li, 2022
Current approaches of nanomedicines in the market and various stage of clinical translation, Yaping Li, 2022
Strategies of engineering nanomedicines for tumor retention, Yaping Li, 2022
Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast

Nanomedicine Targeted Drug Delivery Cancer Therapy Nanoparticles Drug Resistance Chemotherapy Immunotherapy Biomimetic Systems Tumor Microenvironment Drug Formulation

Jianyang Hu - Southern University of Science and Technology

Li-Jing Yang - Wuhan University

Lei Yang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us